Drugs / ZuraPrep
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02296645 | Nov 2014 → Jan 2015 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02221232 | Aug → Oct 2014 | — | Zurex Pharma, Inc. | Terminated | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT02831816 | Aug 2016 → Aug 2017 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02831998 | Jul 2016 → Apr 2017 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02578771 | Oct 2015 → Jan 2016 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZuraPrep | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02831816 ↗ |
| Route | Topical | “Apply topically.” NCT02221232 ↗ |